Elevated tumor markers for monitoring tumor response to immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated tumor markers for monitoring tumor response to immunotherapy

Published:2022-04 Issue: Volume:46 Page:101381
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Yang Yi,Jiang Xiaolin,Liu Yun,Huang Huan,Xiong Yanli,Xiao He,Gong Kan,Li Xuemei,Kuang Xunjie,Yang Xueqin

Funder

Chongqing Municipal Health and Family Planning Commission

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Advances in cancer immunotherapy 2019 - latest trends;Kruger;J Exp Clin Cancer Res,2019

2. iRECIST: a clarification of tumour response assessment in the immunotherapy era;Ferté;Eur J Cancer,2017

3. Treatment after progression in the era of immunotherapy;Billan;Lancet Oncol,2020

4. Immunotherapy by immune checkpoint inhibitors and nuclear medicine imaging: current and future applications;Decazes;Cancers,2020

5. Novel patterns of response under immunotherapy;Borcoman;Ann Oncol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor marker-based RecistTM is superior to RECIST as criteria to predict the long-term benefits of targeted therapy in advanced non-small-cell lung cancer with driver gene mutations;Neoplasia;2024-07

2. Artificial intelligence in the oncology workflow: Applications, limitations, and future perspectives;Artificial Intelligence for Medicine;2024

3. Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients’ blood;Cell Reports Medicine;2023-11

4. Pseudoprogression of thoracic tumor after radiotherapy in the era of immunotherapy: a case series;Frontiers in Oncology;2023-07-28

5. Cell-free multi-omics analysis reveals tumor status-informative signatures in gastrointestinal cancer patients’ plasma;2023-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3